Dimensional Fund Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Dimensional Fund Advisors's XENE Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Xenon Pharmaceuticals (XENE) stake by 158% in Q3 2026, buying an estimated $3.44M and bringing the position to 94,419 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2588.
Dimensional Fund Advisors first reported a position in XENE in Q4 2017 and has held it in 27 quarters since. The position peaked at $20.3M in Q4 2025. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Dimensional Fund Advisors held 94,419 shares of Xenon Pharmaceuticals worth $3.51M as of Q3 2026.
- Dimensional Fund Advisors bought 57,824 Xenon Pharmaceuticals shares in Q3 2026, an estimated $3.44M.
- Xenon Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2588 holding.
- Dimensional Fund Advisors first reported a position in Xenon Pharmaceuticals in Q4 2017 and has held it in 27 quarters since.
- Dimensional Fund Advisors's Xenon Pharmaceuticals position peaked at $20.3M in Q4 2025.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.